MEKC-LIF for Sensitive Discrimination of Six Potential Risk Predictors for Auxiliary Diagnosis of Anesthesia Complications in Clinical Urine Fluids

详细信息    查看全文

• 作者：Fuwei Qi ; Hong Xie ; Zhong Zheng ; Yanhong Shang ; Xiaohua Fan ; Xiuhua Zhao
• 关键词：MEKC ; CFSE ; 96 ; μ derivatization ; Potential risk predictors ; Auxiliary diagnosis ; Anesthesia complications
• 刊名：Chromatographia
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：79
• 期：23-24
• 页码：1665-1670
• 全文大小：
• 刊物类别：Chemistry and Materials Science
• 刊物主题：Chromatography; Proteomics; Pharmacy; Laboratory Medicine;
• 出版者：Springer Berlin Heidelberg
• ISSN：1612-1112
• 卷排序：79

文摘

Biochemical analysis of the abnormalities of urinary metabolites is a powerful auxiliary method for diagnosis of anesthesia complications (AC). It is a cost-effective, time-saving, and complementary diagnosis method that can quickly generate clinical examination results. The current study describes a rapid and sensitive assay for simultaneous determination of six naturally occurring marker metabolites, namely dopamine (DPM), epinephrine (EPR), kynurenine (KNR), anthranilic acid (ATRA), hydroxylproline (OHP), and asymmetric dimethylarginine (ADMA), in urine fluids of diverse AC patients. This novel assay was based on micellar electrokinetic capillary chromatography (MEKC) coupled with highly sensitive laser-induced fluorescence (LIF) detection and high-throughput built-in 96-well microplate (96-μ) precolumn derivatization. 5-Carboxyfluorescein succinimidyl ester (CFSE) was chosen as the fluorescence labeling reagent. After full optimization of the derivatization and separation conditions, the quantization of six target analyses was achieved with good linearity (R2 > 0.998) with a linear range of 0.01–5 μM. The limits of detection (LODs, at S/N > 3) and limits of quantitation (LOQs, at S/N > 10) were determined to be 0.14–1.25 and 0.58–3.61 nM, respectively. The precision data of migration time and peak area, evaluated as relative standard derivations (RSDs), were less than 2.8 and 3.2 % for intraday assay (n = 6), and less than 4.2 and 4.5 % for interday assay (n = 6), respectively, indicating that the proposed method was highly reproducible. Satisfactory recoveries obtained were in the range of 97–106 %, in addition to the good stability of the CFSE derivative products. The feasibility of the proposed method was fully validated by applying quantitative analysis of the target analytes in substantial urine fluids from diverse AC patients.